Notes | 2024 $ ’000 | 2023 $ ’000 | |
Assets | |||
Investments | |||
Financial investments | 11 | ||
Deposits with ceding undertakings | | ||
Reinsurers' share of technical provisions | |||
Provision for unearned premiums | 5 | ||
Claims outstanding | 5 | ||
Debtors | |||
Debtors arising out of direct insurance operations | 12 | ||
Debtors arising out of reinsurance operations | 13 | ||
Other debtors | 14 | ||
Other assets | |||
Cash at bank and in hand | |||
Other | | ||
Prepayments and accrued income | |||
Deferred acquisition costs | 5 | ||
Other prepayments and accrued income | | ||
Total assets |
Notes | 2024 $ ’000 | 2023 $ ’000 | |
Members’ balance and liabilities | |||
Capital and reserves | |||
Members’ balances | |||
Technical provisions | |||
Provision for unearned premiums | 5 | ||
Claims outstanding | 5 | ||
Creditors | |||
Creditors arising out of direct insurance operations | 15 | ||
Creditors arising out of reinsurance operations | 16 | ||
Amounts owed to credit institutions | | ||
Other creditors including taxation and social security | 17 | | |
Accruals and deferred income | |||
Total liabilities | |||
Total liabilities, capital and reserves |
2024 $’000 | 2023 $’000 | |
Members’ balances brought forward at 1 January | ||
Total comprehensive income for the year | ||
Payments of profit to members’ personal reserve funds | ||
Losses collected on closure of underwriting year | ||
Cash calls on open underwriting years | ||
Members agent fees | ||
Net movement on funds in syndicate | ||
Other | ||
Members’ balances carried forward at 31 December |
Notes | 2024 $ ’000 | 2023 $ ’000 | |
Cash flows from operating activities | |||
Profit for the financial year | |||
Adjustments: | |||
Increase in gross technical provisions | |||
(Increase) in reinsurers’ share of gross technical provisions | ( | ( | |
(Increase) in debtors | ( | ( | |
Increase in creditors | |||
(Increase) in deposits received from reinsurers | |||
Movement in other assets/liabilities | ( | ( | |
Foreign exchange | |||
Investment return | ( | ( | |
Net cash flows from operating activities | |||
Cash flows from investing activities | |||
Purchase of equity and debt instruments | | ||
Sale of equity and debt instruments | | ||
Investment income received | |||
Net cash flows from investing activities | | ||
Cash flows from financing activities | |||
Distribution of profit | | ||
Collection of losses | | ||
Injection/(release) of Funds in Syndicate | | ||
Other | | ||
Net cash flows from financing activities | | ||
Net increase in cash and cash equivalents | |||
Cash and cash equivalents at the beginning of the year | |||
Foreign exchange on cash and cash equivalents | ( | ||
Cash and cash equivalents at the end of the year | 18 |